Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Andrew Meds vs Signos

By GLP-1 ScorecardUpdated

Andrew MedsFactor scores not reassessed.
Site position #182

Higher score

SignosFactor scores not reassessed.
Site position #319

Lower score

Score comparison

Andrew Meds has the higher recorded score — 67.1/100 to 61.4/100.

Andrew Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Andrew Meds shows standard monthly prices and lower twelve-month figures for both compounded injections. Ask what is due up front and what happens if you leave early.

Before you choose

Before comparing the headline prices, the Andrew Meds review and the Signos review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, Andrew Meds vs Spry and Breeze Meds vs Signos compare each of them with another graded program, and the list of alternatives to Andrew Meds ranks the programs closest to Andrew Meds on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the WellMedr review covers one graded close to these two, at 63.2/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueAndrew Meds +10
54
44
Dose & formulationEven
64
64
Clinical oversightSignos +3
81
84
Labs & monitoringSignos +18
53
71
FulfillmentAndrew Meds +23
94
71
Contract termsAndrew Meds +47
67
20
Andrew Meds · top barSignos · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricAndrew MedsSignos
WeighScore67.1/10061.4/100
GradeCC
Site position#182#319
Semaglutide$199/mo (standard compounded plan; $149/mo figure on a 12-month plan)$199/mo (6-month plan, compounded)
Tirzepatide$299/mo (standard compounded plan; $229/mo figure on a 12-month plan)$199/mo (starting dose, compounded)
Coverage50 states and D.C. advertised; medication availability variesCoverage not published
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
Andrew Meds

Site position #182 · C

Factor scores not reassessed.

Strengths

  • Lists separate prices for both injections and both plan options
  • Names the independent medical group and three pharmacy partners
  • Describes billing at the start of each plan cycle

What to consider

  • Twelve-month figures do not establish the selected debit schedule or early-exit cost
  • The FAQ says refund requests are handled case by case
  • Confirm your dispensing pharmacy and medication availability
Signos

Site position #319 · C

Factor scores not reassessed.

Strengths

  • Bundles compounded GLP-1 (semaglutide) with an FDA-cleared CGM and app — glucose-guided weight loss, not just medication
  • Starting at $199/mo on a 6-month program, with the CGM included at no extra cost
  • Free rapid shipping; HSA/FSA eligible
  • Real-time glucose insights and app coaching to help sustain results after GLP-1

What to consider

  • Compounded GLP-1s are not FDA-approved finished products
  • Headline price is a 6-month-program rate, not month-to-month
  • Only semaglutide is shown in the program; tirzepatide availability is not confirmed
  • Compounding pharmacy partner and state availability are not published on the landing page

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard